Results 151 to 160 of about 8,771 (219)

JAK Inhibitors for Crohn's Disease: A Systematic Review and Dose-Response Network Meta-Analysis of Efficacy and Safety. [PDF]

open access: yesJGH Open
Qtaishat FA   +12 more
europepmc   +1 more source

First Reported Case of Upadacitinib-Associated Cytomegalovirus Viremia and Suspected Pneumonitis in Ulcerative Colitis. [PDF]

open access: yesACG Case Rep J
Javier-Rojas WJ   +6 more
europepmc   +1 more source

Updated review of Janus kinase inhibitors for the management of inflammatory bowel disease. [PDF]

open access: yesWorld J Gastrointest Pharmacol Ther
Malakar S, Giri S, Jena A, Nath P.
europepmc   +1 more source

Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series. [PDF]

open access: yesReports (MDPI)
Alajroush W   +5 more
europepmc   +1 more source

Upadacitinib for the Treatment of Cutaneous Crohn's Disease Presenting as Lymphangioma Circumscriptum. [PDF]

open access: yesACG Case Rep J
Gerstein B   +6 more
europepmc   +1 more source

Cutaneous and erosive oral lichen planus treated with upadacitinib. [PDF]

open access: yesJAAD Case Rep
Nwogu O   +4 more
europepmc   +1 more source

Alopecia Areata - Effects of Treatment with Upadacitinib - Two Case Reports. [PDF]

open access: yesClin Cosmet Investig Dermatol
Młyńska J   +3 more
europepmc   +1 more source

Upadacitinib for refractory Behcet's syndrome: a multi-centre, single-arm trial. [PDF]

open access: yesArthritis Res Ther
Li J   +19 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy